Titre : | Furanylfentanyl. EMCDDA-Europol Joint Report on a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-furan-2-carboxamide (furanylfentanyl) : In accordance with Article 5 of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances |
Auteurs : | OEDT = EMCDDA ; Europol |
Type de document : | Rapport |
Editeur : | Lisbon : OEDT / EMCDDA, 2017 |
Autre Editeur : | Luxembourg : Publications Office of the European Union |
Collection : | Joint reports |
ISBN/ISSN/EAN : | 978-92-9497-113-5 |
Format : | 21 p. |
Langues: | Anglais |
Discipline : | PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods) |
Mots-clés : |
Thésaurus mots-clés FENTANYL ; DROGUES DE SYNTHESE ; PHENOMENE EMERGENT ; ANALYSE CHIMIQUE ; DIFFUSION DES PRODUITS ; SAISIE ; TRAFIC ; FABRICATION ; MORTALITE ; PHARMACOLOGIE ; TOXICOLOGIE ; CONTROLE DES STUPEFIANTSThésaurus géographique EUROPEOrganismes OEDT |
Résumé : | In November 2016, the EMCDDA and Europol examined the available information on a new psychoactive substance N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-furan-2-carboxamide, commonly known as furanylfentanyl, through a joint assessment. Furanylfentanyl is a synthetic opioid, closely related to fentanyl, which is likely to be a potent opioid narcotic analgesic and may have an abuse liability and dependence potential in humans. The two organisations launched a data collection on this substance for the preparation of a Joint Report as stipulated by Article 5.1 of the Council Decision. The Joint Report was submitted to the Council, the Commission and the European Medicines Agency on 23 January 2017. |
Domaine : | Drogues illicites / Illicit drugs |
URL : | Furanylfentanyl to be placed under control across the EU, News release 15/11/2017 |
Lien : | http://www.emcdda.europa.eu/publications/joint-reports/furanylfentanyl |
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Documents numériques (1)
EMCDDA-Europol_Furanylfentanyl_2017.pdf Adobe Acrobat PDF |
Accueil